Serum Calcium And Phosphateleveelsin Patients With Chronic Myeloid Leukemia Taking Different Dose of Tyrosine Kinase Inhibitors
Objective: chronic myeloid leukemia (CML) is a myeloproliferative confusion characterized by the occurrence of an acquired mutation which affect the hematopoietic stem cell, treatment of CML with tyrosine kinase inhibitors (TKI) has resulted in high response rates compared to the interferon alpha a...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
College of Pharmacy / Mustansiriyah University
2018-03-01
|
| Серія: | Al-Mustansiriyah Journal of Pharmaceutical Sciences |
| Предмети: | |
| Онлайн доступ: | https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/77 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|